FDA unveils long-awaited guidance on AI use to support drug and biologic development
JD Supra The U.S. Food and Drug Administration (FDA) recently published its long-awaited draft guidance on considerations for the use of artificial …
Read the original at JDSupra ↗
- Topics
- HealthcareMedia & Creative Work
- Mentions
- FDAUnited States
- Tags
- AI Use Case
- Tracked via
- Google Alert “AI Risks”